3
Total investments
0
Early stage
0
Mid stage
0
Late stage
13y
Years active
Portfolio
0 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
No investments found
Experience · 5 entries
All (5)
Investments (3)
Board (3)
2019
Member of the Board, representing PharmaMar Group
2019
Sylentis is an European biotechnological company founded in 2006. Sylentis focuses on researching new therapeutic approaches based on gene silencing. Our company is specialised in developing ophtalmologic therapies via interference RNA, a powerful tool for rational drug design.
Most advanced product of the company are treatments for glaucoma and dry eye syndrome.
Sylentis is a wholly owned member of PharmaMar (www.pharmamar.com)
2014
X
XYLAZEL S.A. (Pharmamar Group)
Member of the Board, representing PharmaMar Group
May 2014
2013
B
Biocross
Independent Board Member
May 2013
2006
N
NOSCIRA S.A., PharmaMar Group (former Zeltia Group)
Managing Director
2006
2001
Q
Qualysite consultores
Entrepreneur/ Founding Partner and Technical Director
2001
Investment activity
2013–2019 · 3 investments
Recent (last 2 years)Earlier
Investor lists
Lists that match Belén's portfolio
- Startup investors in Spain1,224 investors